Loading...

Bumrungrad Hospital Public Company Limited

BZ7A.FXETRA
Healthcare
Medical - Care Facilities
3.44
-0.12(-3.37%)

Bumrungrad Hospital Public Company Limited (BZ7A.F) Stock Overview

Explore Bumrungrad Hospital Public Company Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 77.7/100

Key Financials

Market Cap2.7B
P/E Ratio13.87
EPS (TTM)$0.23
ROE0.28%

AI Price Forecasts

1 Week$3.44
1 Month$3.73
3 Months$4.71
1 Year Target$5.39

BZ7A.F Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bumrungrad Hospital Public Company Limited (BZ7A.F) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $5.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.87 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
1.35%
1.35%
Profit Growth
9.46
10.97%
EPS Growth
9.46
11.01%
Operating Margin
34.90%
7.83%
ROE
28.00%
10.97%
Dividend Yield
0.00%
39.57%
Analyst Recommendations data is not available for BZ7A.FAnalyst Recommendations details for BZ7A.F are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.

CEO

Artirat Charukitpipat

Headquarters

33 Sukhumvit Soi 3 (Nana Nua), Bangkok

Founded

2007

Frequently Asked Questions

;